Results 141 to 150 of about 1,813,644 (300)

Frequency and predictors of postoperative atrial fibrillation development after aortic valve replacement in patients with aortic stenosis

open access: yesМедицина неотложных состояний
Background. Aortic stenosis is the most frequent form of heart valve pathology, the prevalence of which increases with age. Calcification of the bicuspid aortic valve and degenerative changes of the tricuspid valve are the most common causes of surgical ...
F. Hassanzadeh Ghasabeh   +2 more
doaj   +1 more source

AVIATOR: An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm

open access: yes, 2019
: Objectives: Current national registries are lacking detailed pathology-driven analysis and long-term patients outcomes. The Heart Valve Society (HVS) aortic valve (AV) repair research network started the Aortic Valve Insufficiency and ascending aorta ...
Soliman, Said   +128 more
core  

Post‐Market Analysis of the Xenios Console With the Xlung Tubing Kit 230 for Extracorporeal Membrane Oxygenation After Cardiac Surgery

open access: yesArtificial Organs, EarlyView.
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci   +9 more
wiley   +1 more source

Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement

open access: yesJACC: Cardiovascular Interventions, 2018
Mario Gössl, Aisha Ahmed
openaire   +1 more source

Geometry‐Related Technical Complications After LVAD Implantation: Impact on Device Dysfunction and Clinical Outcomes

open access: yesArtificial Organs, EarlyView.
Preventable geometric failure modes, such as outflow graft kinking and inflow malposition, frequently cause HeartMate 3 dysfunction. This study identifies these complications as key drivers of device‐related morbidity, highlighting the importance of optimized surgical positioning to ensure long‐term device performance and improved clinical outcomes ...
Ali Saad Merzah   +17 more
wiley   +1 more source

Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?

open access: yesJACC: Cardiovascular Interventions, 2017
Matteo Pagnesi   +6 more
openaire   +1 more source

Totally endoscopic aortic valve replacement after open surgical and subsequent transcatheter aortic valve replacement

open access: yes
Transcatheter aortic valve replacement is increasingly being offered to younger and lower risk patients, including patients with previous surgical aortic valve replacement.
Hillen, William   +6 more
core   +1 more source

Percutaneous pulmonary valve implantation in humans - Results in 59 consecutive patients [PDF]

open access: yes, 2005
Background - Right ventricular outflow tract (RVOT) reconstruction with valved conduits in infancy and childhood leads to reintervention for pulmonary regurgitation and stenosis in later life.Methods and Results - Patients with pulmonary regurgitation ...
Coats, L   +12 more
core  

Standardized Reporting of Cardiac Magnetic Resonance Examinations in Children With Cardiac Diseases and Adults With Congenital Heart Disease: A Scientific Statement From the Association for European Pediatric and Congenital Cardiology (AEPC) and the International Society for Magnetic Resonance in Medicine (ISMRM)

open access: yes
Journal of Magnetic Resonance Imaging, EarlyView.
Francesca Raimondi   +26 more
wiley   +1 more source

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

open access: yesArtificial Organs, EarlyView.
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy